Daunorubicin and febrile neutropenia Patient Reports February 11, 2012

Daunorubicin Side Effects Report #4646223-8
Daunorubicin side effect was reported by a Consumer or non-health professional from on Apr 22, 2005. Male patient, weighting 179.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , febrile neutropenia, orthostatic hypotension. Daunorubicin dosage: 45 MG/M2/DAY, DAYS 1-3, IV. During the same period patient was treated with CYTARABINE, ZOSUQUIDAR TRIHYDROCHLORIDE, NEUPOGEN. Patient recovered.

Daunorubicin Side Effects Report #4578502-7
Daunorubicin side effect was reported by a Health Professional from on Feb 04, 2005. Male patient, weighting 139.0 lb, was diagnosed with erythroleukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood bilirubin increased, deep vein thrombosis , febrile neutropenia, pleural effusion, staphylococcal sepsis. Daunorubicin dosage: 45 MG/M2 QD D 1-3 INTRAVENOU. During the same period patient was treated with CYTARABINE. Patient recovered.

Daunorubicin Side Effects Report #4643325-7
Daunorubicin side effect was reported by a Health Professional from on Apr 04, 2005. Female patient, 86 years of age, weighting 105.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, ejection fraction decreased, febrile neutropenia, fluid overload, heart rate increased, palpitations, platelet count decreased, staphylococcal sepsis. Daunorubicin dosage: 45 MG/M2 OTHER. During the same period patient was treated with NEUPOGEN. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4576707-2
Daunorubicin side effect was reported by a Pharmacist from on Nov 10, 2004. Female patient, 73 years of age, weighting 120.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, febrile neutropenia, sinus tachycardia. Daunorubicin dosage: 45MG/M2. During the same period patient was treated with CIPROFLOXACIN, SYNTHROID. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #4578607-0
Daunorubicin side effect was reported by a Consumer or non-health professional from on Feb 08, 2005. Female patient, 73 years of age, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood bilirubin increased, cough, febrile neutropenia, sinus tachycardia. Daunorubicin dosage: 45 MG/M2 OTHER. During the same period patient was treated with CYTARABINE, CIPROFLOXACIN, SYNTHROID, CALTRATE PLUS, GLUCOSAMINE, ACTONEL. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4684650-3
Daunorubicin side effect was reported by a Pharmacist from on May 26, 2005. Male patient, 69 years of age, weighting 149.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: back pain , brain herniation, cerebral haematoma, cerebral haemorrhage, confusional state, dysphasia, febrile neutropenia, feeling jittery, hallucination. Daunorubicin dosage: 45 MG/M2 OTHER. Patient died on 05/05/2005.

Daunorubicin Side Effects Report #4704844-8
Daunorubicin side effect was reported by a Pharmacist from on June 13, 2005. Male patient, 65 years of age, weighting 221.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain , arrhythmia supraventricular, fatigue, febrile neutropenia, hypotension, pancreatitis, pneumonitis, renal impairment. Daunorubicin dosage: 45MG/M2 OTHER. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4709533-1
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on June 23, 2005. Male patient, 65 years of age, weighting 170.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: back pain , catheter related infection, febrile neutropenia, immunosuppression, intervertebral disc disorder, myalgia, pyrexia, respiratory distress. Daunorubicin dosage: 45MG/M2 OTHER. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #4551302-X
Daunorubicin side effect was reported by a Pharmacist from on Dec 27, 2004. Male patient, 64 years of age, weighting 187.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonitis, septic shock. Daunorubicin dosage: 240 MG/M2. Patient was hospitalized. Patient died on 11/30/2004.


Daunorubicin Side Effects Report #4551979-9
Daunorubicin side effect was reported by a Consumer or non-health professional from on Jan 03, 2005. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, lobar pneumonia, lung consolidation, septic shock. Daunorubicin dosage: 240 MG/M2 FREQ. During the same period patient was treated with CYTARABINE, NEUPOGEN. Patient was hospitalized. Patient died.

Daunorubicin Side Effects Report #4704602-4
Daunorubicin side effect was reported by a Pharmacist from on June 13, 2005. Male patient, 64 years of age, weighting 187.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, pneumonitis, septic shock. Daunorubicin dosage: 240 MG/M2. Patient was hospitalized. Patient died on 11/30/2004.

Daunorubicin Side Effects Report #4705919-X
Daunorubicin side effect was reported by a Physician from on Jan 03, 2005. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: condition aggravated, confusional state, febrile neutropenia, lobar pneumonia, lung consolidation, pneumonitis, septic shock. Daunorubicin dosage: 240 MG/M2. During the same period patient was treated with CYTARABINE, CIPROFLOXACIN, ITRACONAZOLE. Patient was hospitalized. Patient died.

Daunorubicin Side Effects Report #4599652-5
Daunorubicin side effect was reported by a Consumer or non-health professional from on Feb 18, 2005. Female patient, 62 years of age, weighting 219.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: catheter related infection, febrile neutropenia, neutrophil count decreased. Daunorubicin dosage: 45 MG/M2 OTHER. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5333194-4
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on May 21, 2007. Male patient, 45 years of age, weighting 158.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, fungal infection , multi-organ failure, respiratory failure, zygomycosis. Daunorubicin dosage: 90 MG/M2 Q DAY X 3 DAYS IV DRIP. During the same period patient was treated with CYTARABINE, CIPROFLOXACIN, PENICILLIN VK, AMLODIPINE, ACYCLOVIR, FLUCONAZOLE. Patient died on 05/10/2007.


Daunorubicin Side Effects Report #4627083-8
Daunorubicin side effect was reported by a Physician from on Mar 17, 2005. Male patient, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: confusional state, coordination abnormal, febrile neutropenia, hypotension, respiratory distress, urinary incontinence . Daunorubicin dosage: 45 MG/M2 OTHER. Patient was hospitalized. Patient died on 02/23/2005.

Daunorubicin Side Effects Report #4663136-6
Daunorubicin side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: confusional state, coordination abnormal, disease progression, febrile neutropenia, hypotension, infusion related reaction, respiratory distress, urinary incontinence . Daunorubicin dosage: 45MG/M2 OTHER. Patient was hospitalized. Patient died on 02/23/2005.

Daunorubicin Side Effects Report #4736243-7
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2005. Male patient, weighting 179.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blast cells present, blood culture positive, candidiasis, computerised tomogram abnormal, febrile neutropenia, fluid overload, infection , leukaemia cutis, lung infection. Daunorubicin dosage: unknown. During the same period patient was treated with CYTARABINE. Patient died.

Daunorubicin Side Effects Report #5974051-X
Daunorubicin side effect was reported by a Physician from on Nov 11, 2008. Male patient, child 9 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: central nervous system lesion, febrile neutropenia, grand mal convulsion, ileus paralytic, paraesthesia, postictal state, tumour lysis syndrome, visual impairment. Daunorubicin dosage: 30MG/M2 IV. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5971747-0
Daunorubicin side effect was reported by a Physician from on Nov 11, 2008. Female patient, child 11 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atonic urinary bladder, febrile neutropenia, grand mal convulsion, ileus paralytic, neuropathy peripheral, paraesthesia, reversible posterior leukoencephalopathy syndrome, tardive dyskinesia. Daunorubicin dosage: 30MG/M2 ON DAYS 8, 15, AND 29. Patient was hospitalized. Patient recovered.


Daunorubicin Side Effects Report #4894867-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 27, 2006. Male patient, weighting 246.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: asthenia, blood culture positive, febrile neutropenia, leukostasis, sepsis , sputum culture positive, staphylococcal infection , transient ischaemic attack. Daunorubicin dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ELSPAR, VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 01/20/2006.

Daunorubicin Side Effects Report #5001627-9
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2006. Male patient, weighting 177.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: deep vein thrombosis , febrile neutropenia, pneumonia , pulmonary embolism , pulmonary infarction. Daunorubicin dosage: 462 MG. During the same period patient was treated with ELSPAR, METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5390181-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, weighting 183.0 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, aspergillosis, blood bilirubin increased, febrile neutropenia, fungaemia, hepatic function abnormal, hepatic steatosis. Daunorubicin dosage: 4 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Daunorubicin Side Effects Report #5465330-3
Daunorubicin side effect was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Male patient, weighting 138.7 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: colitis, constipation , faecaloma, febrile neutropenia, gastritis, gastrointestinal necrosis, hyponatraemia, inappropriate antidiuretic hormone secretion, large intestine perforation. Daunorubicin dosage: 172 MG. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.